| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 5,054,000 | 4,410,000 | 18,229,000 | 19,207,000 | | Cost of Revenue | 3,043,000 | 2,693,000 | 13,024,000 | 13,568,000 | | | Gross Profit | 2,011,000 | 1,717,000 | 5,205,000 | 5,639,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 649,000 | 648,000 | 2,054,000 | 1,907,000 | | Non Recurring | 19,000 | (146,000) | (109,000) | 235,000 | | Others | 1,000 | 2,000 | 224,000 | (208,000) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,342,000 | 1,213,000 | 3,036,000 | 3,705,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (16,000) | (377,000) | 438,000 |
-
| | Earnings Before Interest And Taxes | 1,473,000 | 979,000 | 3,474,000 | 3,705,000 | | Interest Expense | 2,000 |
-
| 466,000 | 11,000 | | Income Before Tax | 1,471,000 | 979,000 | 3,008,000 | 3,694,000 | | Income Tax Expense | 541,000 | 365,000 | 862,000 | 1,117,000 | | Minority Interest |
-
|
-
|
-
| (139,000) | | | | Net Income From Continuing Ops | 930,000 | 614,000 | 2,188,000 | 2,633,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 1,840,000 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 930,000 | 2,454,000 | 2,188,000 | 2,633,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $930,000 | $2,454,000 | $2,188,000 | $2,633,000 |
|
4.81% Nasdaq 
Income Statement
